An
auto-injector is a small, pen shaped device, which contains a
hypodermic needle used for delivering a fixed dose of drug to patients.
The drug is delivered by inserting the syringe needle at the desired
site of injection, and on a push of a button. The site of insertion
usually depends upon the nature of the drug to be administered, however
intramuscular route is the preferred route of administration. Most of
these auto-injector devices are spring loaded, pre filled syringes, and
are used during serious allergic reactions also known as anaphylaxis or
anaphylactic shock, and also in the cases of rheumatoid arthritis, and
multiple sclerosis among others. Auto-Injectors are easy to use, and
intended for self-administration by patients or any other care taker or
personnel at home.
Increasing
prevalence and incidences of anaphylaxis and food allergies around the
world is majorly responsible for the growth of the global auto-injectors
market. According to American Academy of Allergy Asthma and Immunology
(AAAAI) around 15 Mn people in U.S. suffered from food allergies in
2015, while 17 Mn people in Europe out of which 3.5 Mn children suffered
from food allergies in 2015 according to European Academy of Allergy
and Clinical Immunology (EAACI). World Health Organization (WHO)
estimated around 200 – 250 Mn people in the world suffered from food
allergies in 2015. The increasing prevalence of anaphylaxis is
increasing demand for adrenaline, and epinephrine auto-injectors, in the
global market. Furthermore, new formulations and new drug delivery
systems, combined with innovation and developments in the biological
drugs segments are expected to drive the growth of the global
auto-injectors market during the forecast period of 2016-2024. Rising
self-medication practices, growing demand for targeted drug delivery
systems for treatments of chronic diseases, coupled with government
reimbursements and marketing approvals for auto-injectors are some other
factors that are fuelling the demand for auto-injectors
in the global market. However, higher prices for injectors, lack of
practices of self-injection in emerging countries, and presence of
substitute products are certain factors that are restraining the growth
of the global auto-injectors market.
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/12580
The global market for auto-injectors is segmented on basis of product, application, distribution channels and geography:
- Segmentation by Product Type
- Disposable Auto-injectors
- Reusable Auto-injectors
- Segmentation by Application
- Anaphylaxis
- Multiple sclerosis
- Rheumatoid Arthritis
- Other emergency conditions
- Segmentation by Distribution Channels
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Based
on product type segmentation, the disposable auto-injectors dominated
the global auto-injectors market in 2015 in terms of value, and it is
expected to continue this dominance during the forecast period of
2016-2024. Factors such as rising patient awareness and inclination of
patients towards self-administration, increasing demand for
auto-injectors due to increasing prevalence of anaphylaxis, and other
emergency conditions, combined with easy to use disposable
auto-injectors, are some factors that are expected to drive the growth
of disposable auto-injectors segment in the global auto-injectors market
during the forecast period of 2016-2024. Based on applications, the
anaphylaxis segment is expected to dominate the global auto-injectors
market during the forecast period of 2016-2024.
On
the basis of regional presence, global auto-injectors market is
segmented into five key regions viz. North America, Latin America,
Europe, Asia Pacific, and Middle East & Africa. North America is
expected to lead the global auto-injectors market in terms of revenue
owing to the advanced healthcare infrastructure, advancements in medical
devices technologies, higher demand for quality products, and
availability of reimbursement policies. According to World Health
Organization (WHO), an estimated 26 Mn people in U.S. suffered from
allergies, and according to Healthline Networks, an estimated 400,000
people in the U.S., and 2.5 Mn people around the world suffered from
multiple sclerosis in 2015 with over 400 new cases of multiple sclerosis
identified each week in the U.S. Asia Pacific market is anticipated to
grow at the fastest growth rate during the forecast period, owing to
factors such as increasing anaphylaxis and food allergies in countries
such as China, Japan, Singapore, Australia and India. According to
Australian Society of Clinical Immunology and Allergy (ASCIA), Australia
and New Zealand topped the list of countries with most prevalence of
food allergies in 2015 followed by Japan, Singapore, and Thailand.
Growing medical tourism and high growth of the medical devices industry
in these countries, is expected to drive the growth of the global
auto-injectors market during the forecast period of 2016-2024.
To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/12580
Some
of the major players in global auto-injectors market are Pfizer, Inc.,
Novartis International AG, Antares Pharma, Inc., Mylan N.V., Biogen
Idec, Inc., Becton, Dickinson and Company, Unilife Corporation,
Scandinavian Health Ltd. and Ypsomed Holdings AG among others.
No comments:
Post a Comment